| 000 | 01834 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513225833.0 | ||
| 264 | 0 | _c20010208 | |
| 008 | 200102s 0 0 eng d | ||
| 022 | _a0014-4827 | ||
| 024 | 7 |
_a10.1006/excr.2000.5085 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRiccio, M | |
| 245 | 0 | 0 |
_aNuclear localization of cystatin B, the cathepsin inhibitor implicated in myoclonus epilepsy (EPM1). _h[electronic resource] |
| 260 |
_bExperimental cell research _cJan 2001 |
||
| 300 |
_a84-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCathepsin B _xantagonists & inhibitors |
| 650 | 0 | 4 | _aCell Compartmentation |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aCell Nucleus _xmetabolism |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCerebellum _xcytology |
| 650 | 0 | 4 | _aCystatin B |
| 650 | 0 | 4 |
_aCystatins _xmetabolism |
| 650 | 0 | 4 |
_aCytoplasm _xmetabolism |
| 650 | 0 | 4 |
_aCytoskeleton _xmetabolism |
| 650 | 0 | 4 |
_aEpilepsies, Myoclonic _xetiology |
| 650 | 0 | 4 | _aFluorescent Antibody Technique |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aMuscle, Skeletal _xcytology |
| 650 | 0 | 4 |
_aNerve Growth Factor _xpharmacology |
| 650 | 0 | 4 |
_aNeuroblastoma _xmetabolism |
| 650 | 0 | 4 |
_aNeurons _xcytology |
| 650 | 0 | 4 |
_aNuclear Matrix _xmetabolism |
| 650 | 0 | 4 |
_aOsteosarcoma _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 700 | 1 | _aDi Giaimo, R | |
| 700 | 1 | _aPianetti, S | |
| 700 | 1 | _aPalmieri, P P | |
| 700 | 1 | _aMelli, M | |
| 700 | 1 | _aSanti, S | |
| 773 | 0 |
_tExperimental cell research _gvol. 262 _gno. 2 _gp. 84-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/excr.2000.5085 _zAvailable from publisher's website |
| 999 |
_c11079399 _d11079399 |
||